Learn More
Medchemexpress LLC Ibezapolstat (ACX-362E) | 1275582-97-2 | 98.0% | 100 MG

Supplier: Medchemexpress LLC HY128357100MG
Ibezapolstat (ACX-362E) is a first-in-class, orally active DNA polymerase IIIC inhibitor developed for the research of *C. difficile* infection (CDI). It demonstrates antibacterial activity against a broad spectrum of *C. difficile* pathogens by inhibiting DNA pol IIIC from aerobic and low G+C Gram-positive bacteria. This compound is poorly absorbed, suggesting potential for high local concentrations at the site of infection in the colon, and has shown strong anti-*C. difficile* properties in vivo.
- First-in-class, orally active DNA polymerase IIIC inhibitor
- Developed for *C. difficile* infection (CDI) research
- Exhibits antibacterial activity against *C. difficile* pathogens
- Inhibits DNA pol IIIC from aerobic and low G+C Gram-positive bacteria
- Poorly absorbed in vivo, promoting local concentration at infection site
- Demonstrates strong anti-*C. difficile* properties in animal models
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.